GSK3B and cancer: It has been reported that apocynin can primarily inhibit cancer progression in various cancers by blocking the PI3K-AKT-GSK3β axis and downregulating cell cycle proteins, as well as reducing Ki-67 protein expression in tumors (Kato et al. 2015; Jantaree et al. 2017).